Richard A Brigandi Selected Research

vestipitant

3/2015

Intravenous Pharmacokinetics, Local Tolerability, and Hemolysis of an SBE7-β-Cyclodextrin Formulation of the Neurokinin-1 Receptor Antagonist Vestipitant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Brigandi Research Topics

Disease

1	Acne Vulgaris 01/2019
1	Anemia 06/2016
1	Hypoxia (Hypoxemia) 06/2016
1	Chronic Renal Insufficiency 06/2016
1	Hemolysis 03/2015
1	Nausea 03/2015
1	Vomiting 03/2015
1	Postoperative Nausea and Vomiting (PONV) 03/2015
1	Hematologic Neoplasms (Hematological Malignancy) 10/2014
1	Multiple Myeloma 10/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2004

Drug/Important Bio-Agent (IBA)

1	GSK1940029IBA 01/2019
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 01/2019
1	EnzymesIBA 01/2019
1	Monounsaturated Fatty AcidsIBA 01/2019
1	Prolyl-Hydroxylase InhibitorsIBA 06/2016
1	GSK1278863IBA 06/2016
1	Erythropoietin FDA Link 06/2016
1	Neurokinin-1 Receptor AntagonistsIBA 03/2015
1	vestipitantIBA 03/2015
1	afuresertibIBA 10/2014
1	Biological ProductsIBA 06/2004